BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11574796)

  • 1. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial.
    Lewis RJ; Berry DA; Cryer H; Fost N; Krome R; Washington GR; Houghton J; Blue JW; Bechhofer R; Cook T; Fisher M
    Ann Emerg Med; 2001 Oct; 38(4):397-404. PubMed ID: 11574796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. DCLHb Traumatic Hemorrhagic Shock study group.
    Sloan EP; Koenigsberg M; Houghton J; Gens D; Cipolle M; Runge J; Mallory MN; Rodman G
    Acad Emerg Med; 1999 Dec; 6(12):1203-9. PubMed ID: 10609921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diaspirin cross-linked hemoglobin infusion did not influence base deficit and lactic acid levels in two clinical trials of traumatic hemorrhagic shock patient resuscitation.
    Sloan EP; Koenigsberg MD; Philbin NB; Gao W; ;
    J Trauma; 2010 May; 68(5):1158-71. PubMed ID: 20145575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
    Moore EE; Moore FA; Fabian TC; Bernard AC; Fulda GJ; Hoyt DB; Duane TM; Weireter LJ; Gomez GA; Cipolle MD; Rodman GH; Malangoni MA; Hides GA; Omert LA; Gould SA;
    J Am Coll Surg; 2009 Jan; 208(1):1-13. PubMed ID: 19228496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency Resuscitation of Patients Enrolled in the US Diaspirin Cross-linked Hemoglobin (DCLHb) Clinical Efficacy Trial.
    Sloan EP; Koenigsberg M; Weir WB; Clark JM; O'Connor R; Olinger M; Cydulka R
    Prehosp Disaster Med; 2015 Feb; 30(1):54-61. PubMed ID: 25499006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A safety assessment of diaspirin cross-linked hemoglobin (DCLHb) in the treatment of hemorrhagic, hypovolemic shock.
    Przybelski RJ; Daily EK; Micheels J; Sloan E; Mols P; Corne L; Koenigsberg MD; Bickell WH; Thompson DR; Harviel JD; Cohn SM
    Prehosp Disaster Med; 1999; 14(4):251-64. PubMed ID: 10915412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock index and prediction of traumatic hemorrhagic shock 28-day mortality: data from the DCLHb resuscitation clinical trials.
    Sloan EP; Koenigsberg M; Clark JM; Weir WB; Philbin N
    West J Emerg Med; 2014 Nov; 15(7):795-802. PubMed ID: 25493120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposed consent process in studies that use an exception to informed consent.
    Sloan EP; Nagy K; Barrett J
    Acad Emerg Med; 1999 Dec; 6(12):1283-91. PubMed ID: 10609931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical and legal issues in emergency research: barriers to conducting prospective randomized trials in an emergency setting.
    Morrison CA; Horwitz IB; Carrick MM
    J Surg Res; 2009 Nov; 157(1):115-22. PubMed ID: 19765724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community.
    Shah AN; Sugarman J
    Ann Emerg Med; 2003 Jan; 41(1):72-8. PubMed ID: 12514685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial.
    Sloan EP; Koenigsberg M; Gens D; Cipolle M; Runge J; Mallory MN; Rodman G
    JAMA; 1999 Nov; 282(19):1857-64. PubMed ID: 10573278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the exception from informed consent regulations in research.
    Mosesso VN; Cone DC
    Acad Emerg Med; 2005 Nov; 12(11):1031-9. PubMed ID: 16264070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the Revised Trauma Score as an entry criterion in traumatic hemorrhagic shock studies: data from the DCLHb clinical trials.
    Sloan EP; Koenigsberg M; Clark JM; Desai A
    Prehosp Disaster Med; 2012 Aug; 27(4):330-44. PubMed ID: 22840198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusion.
    Pape A; Kleen M; Kemming G; Meisner F; Meier J; Habler O
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1328-37. PubMed ID: 15504197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial.
    Kipnis K; King NM; Nelson RM
    Am J Bioeth; 2006; 6(3):18-21. PubMed ID: 16754441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postinjury resuscitation with human polymerized hemoglobin prolongs early survival: a post hoc analysis.
    Bernard AC; Moore EE; Moore FA; Hides GA; Guthrie BJ; Omert LA; Gould SA; Rodman GH;
    J Trauma; 2011 May; 70(5 Suppl):S34-7. PubMed ID: 21841568
    [No Abstract]   [Full Text] [Related]  

  • 18. Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock.
    Sloan EP; Koenigsberg M; Brunett PH; Bynoe RP; Morris JA; Tinkoff G; Dalsey WC; Ochsner MG;
    J Trauma; 2002 May; 52(5):887-95. PubMed ID: 11988654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Diaspirin Crosslinked Hemoglobin (DCLHb) on microcirculation and local tissue pO2 of striated skin muscle following resuscitation from hemorrhagic shock.
    Hungerer S; Nolte D; Botzlar A; Messmer K
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(5):455-71. PubMed ID: 16893810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.